Abstract:Sortase A (SrtA) anchors surface proteins to the cell wall envelope, and it has attracted increasing interesting as a potential antivirulence target. Several small-molecule inhibitors for SrtA have been developed, but target validation remains largely underexplored. Herein, we report a new class of SrtA inhibitors that supports antivirulence therapy through small-molecule targeting of SrtA. Tideglusib (TD), a drug candidate for myotonic dystrophy, was outstanding in high-throughput screening. A concise synthetic route quickly provided TD analogues, and the structure–activity relationships for SrtA inhibition have been established from those analogues. Several compounds largely retained the in vitro potency and exhibited a better solubility than TD. Additionally, TD attenuated virulence-related phenotypes in vitro and protected mice against lethal S. aureus USA300 bacteremia. Our study indicates that TD and its analogues could be new candidates as SrtA inhibitors with potential in the development of new antivirulence agents.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00803?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00803</a>.NMR spectrum for TD analogues, representative HPLC, chemical structures of compounds used as control in this study, and no PAINS-containing properties of TD and TD32 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00803/suppl_file/jm0c00803_si_001.pdf">PDF</a>)Docking model of TD bound to SrtA (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00803/suppl_file/jm0c00803_si_002.pdb">PDB</a>)Docking model of TD32 bound to SrtA (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00803/suppl_file/jm0c00803_si_003.pdb">PDB</a>)Molecular formula strings and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00803/suppl_file/jm0c00803_si_004.csv">CSV</a>)This article has not yet been cited by other publications.

Analogues Of Sb-203207 As Inhibitors Of Trna Synthetases

Synthesis and Biological Evaluation of 1,3-Dideazapurine-Like 7-Amino-5-Hydroxymethyl-Benzimidazole Ribonucleoside Analogues as Aminoacyl-tRNA Synthetase Inhibitors

Family-wide analysis of aminoacyl-sulfamoyl-3-deazaadenosine analogues as inhibitors of aminoacyl-tRNA synthetases

Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.

Design, Synthesis, and Proof-of-Concept of Triple-Site Inhibitors against Aminoacyl-tRNA Synthetases

4-Alkoxy-3-arylfuran-2(5h)-ones As Inhibitors of Tyrosyl-Trna Synthetase: Synthesis, Molecular Docking and Antibacterial Evaluation.

Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles

Selective Inhibitors of Bacterial T-Rna-(n(1)g37) Methyltransferase (trmd) That Demonstrate Novel Ordering of the Lid Domain.

4-Hydroxy-3-(naphthalen-1-ylmethyl)thiophen-2(5h)-one As Inhibitors of Tyrosyl-Trna Synthase: Synthesis, Molecular Docking and Antibacterial Evaluation

Research Advances of Aminoacyl-tRNA Synthetase Inhibitors As Novel Anti-infective Agents

Adenosine Analogs As Inhibitors of Tyrosyl-Trna Synthetase: Design, Synthesis and Antibacterial Evaluation.

Tyrosyl-Trna Synthetase Inhibitors As Antibacterial Agents: Synthesis, Molecular Docking and Structure-Activity Relationship Analysis of 3-Aryl-4-arylaminofuran-2(5h)-ones

A Facile Synthesis and M. Tuberculosis Leucyl-tRNA Synthetase Inhi-bitory Activity of Novel 3-Arylvinylquinoxaline-2-carboxylic Acids

Structure-guided optimization and mechanistic study of a class of quinazolinone-threonine hybrids as antibacterial ThrRS inhibitors

Structural Basis for Full-Spectrum Inhibition of Translational Functions on a Trna Synthetase

[New Inhibitors Targeting Bacterial RNA Polymerase].

Synthesis and Evaluation of New Tyrosyl-Trna Synthetase Inhibitors As Antibacterial Agents Based on a N2-(arylacetyl)glycinanilide Scaffold

The Role of a Novel Auxiliary Pocket in Bacterial Phenylalanyl-tRNA Synthetase Druggability

An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site

Tideglusib and Its Analogues As Inhibitors of Staphylococcus aureus SrtA

Potent and Selective Inhibitors of Staphylococcus Epidermidis Tryptophanyl-Trna Synthetase.